Jack Welch

770 total citations
13 papers, 425 citations indexed

About

Jack Welch is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Jack Welch has authored 13 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in Jack Welch's work include Ethics in Clinical Research (2 papers), Colorectal and Anal Carcinomas (2 papers) and Gastrointestinal Tumor Research and Treatment (2 papers). Jack Welch is often cited by papers focused on Ethics in Clinical Research (2 papers), Colorectal and Anal Carcinomas (2 papers) and Gastrointestinal Tumor Research and Treatment (2 papers). Jack Welch collaborates with scholars based in United Kingdom, United States and Australia. Jack Welch's co-authors include Laura Crane, Elizabeth Pellicano, A. Bowcock, Richard H. Wilson, D. Papamichael, Jan P. van Meerbeeck, Patrick M. Boland, Kyle C. McKenna, Erwin G. Van Meir and Jeffrey E. Gershenwald and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Jack Welch

13 papers receiving 418 citations

Peers

Jack Welch

ONCOL

PRM

OPHTH

Philippa Evans United Kingdom

Kathryn Bailey United Kingdom

Michal Berkenstadt Israel

Deborah L. McCartney United Kingdom

Virginia Williams Australia

Rui Xiang United States

Lee Robinson United States

Colleen M. Parker United States

Paul Chamberlain United States

Maggie Phillips United States

Philippa Evans United Kingdom

Jack Welch

97 ×0.6

70 ×0.4

38 ×0.4

ONCOL

49 ×0.6

PRM

45 ×0.8

OPHTH

Citations per year, relative to Jack Welch Jack Welch (= 1×) peers Philippa Evans

Countries citing papers authored by Jack Welch

Since Specialization

Citations

This map shows the geographic impact of Jack Welch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack Welch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack Welch more than expected).

Fields of papers citing papers by Jack Welch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack Welch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack Welch. The network helps show where Jack Welch may publish in the future.

Co-authorship network of co-authors of Jack Welch

This figure shows the co-authorship network connecting the top 25 collaborators of Jack Welch. A scholar is included among the top collaborators of Jack Welch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack Welch. Jack Welch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Berrington, Ann, Shantini Paranjothy, Rhiannon K Owen, et al.. (2023). A conceptual framework for characterising lifecourse determinants of multiple long-term condition multimorbidity. SHILAP Revista de lepidopterología. 13. 2593161055–2593161055. 4 indexed citations

Pedersen, Katrina S., Nathan R. Foster, Michael J. Overman, et al.. (2021). ZEBRA: A Multicenter Phase II Study of Pembrolizumab in Patients with Advanced Small-Bowel Adenocarcinoma. Clinical Cancer Research. 27(13). 3641–3648. 38 indexed citations

Pedersen, Katrina S., Nathan R. Foster, Michael J. Overman, et al.. (2019). ZEBRA: an ACCRU/IRCI multicenter phase 2 study of pembrolizumab in patients with advanced small bowel adenocarcinoma (SBA). Annals of Oncology. 30. iv128–iv128. 8 indexed citations

Rao, Sheela, Francesco Sclafani, Cathy Eng, et al.. (2018). InterAACT: A multicentre open label randomised phase II advanced anal cancer trial of cisplatin (CDDP) plus 5-fluorouracil (5-FU) vs carboplatin (C) plus weekly paclitaxel (P) in patients (pts) with inoperable locally recurrent (ILR) or metastatic treatment naïve disease - An International Rare Cancers Initiative (IRCI) trial. Annals of Oncology. 29. viii715–viii716. 16 indexed citations

Hargreaves, Dougal, Claire Lemer, Jacqueline Cornish, et al.. (2018). Measuring and improving the quality of NHS care for children and young people. Archives of Disease in Childhood. 104(7). 618–621. 6 indexed citations

Crane, Laura, et al.. (2018). ‘Something needs to change’: Mental health experiences of young autistic adults in England. Autism. 23(2). 477–493. 198 indexed citations

Crane, Laura, et al.. (2017). Know your normal: mental health in young autistic adults. 9 indexed citations

Morgan, Chris, Mishka Kohli Cira, Fredrick Chite Asirwa, et al.. (2017). The Kenya cancer research and control stakeholder program: Evaluating a bilateral partnership to strengthen national cancer efforts. Journal of Cancer Policy. 17. 38–44. 11 indexed citations

Topazian, Hillary M., Mishka Kohli Cira, Sanford M. Dawsey, et al.. (2016). Joining forces to overcome cancer: The Kenya cancer research and control stakeholder program. Journal of Cancer Policy. 7. 36–41. 22 indexed citations

10.

Sclafani, Francesco, Richard Adams, Cathy Eng, et al.. (2015). InterAACT: An international multicenter open label randomized phase II advanced anal cancer trial comparing cisplatin (CDDP) plus 5-fluorouracil (5-FU) versus carboplatin (CBDCA) plus weekly paclitaxel (PTX) in patients with inoperable locally recurrent (ILR) or metastatic disease.. Journal of Clinical Oncology. 33(3_suppl). TPS792–TPS792. 10 indexed citations

11.

Luke, Jason J., Pierre L. Triozzi, Kyle C. McKenna, et al.. (2014). Biology of advanced uveal melanoma and next steps for clinical therapeutics. Pigment Cell & Melanoma Research. 28(2). 135–147. 69 indexed citations

12.

Greillier, Laurent, Paul Baas, Jack Welch, et al.. (2011). Does disease control rate (DCR) at 9 and 18 weeks predict overall survival (OS) in patients with malignant pleural mesothelioma (MPM)? An individual patient data combined analysis of 10 European Organisation for Research and Treatment of Cancer (EORTC) Lung Cancer Group (LCG) studies.. Journal of Clinical Oncology. 29(15_suppl). 7025–7025. 1 indexed citations

13.

Gaafar, Rabab, Veerle Surmont, Giorgio V. Scagliotti, et al.. (2010). A double-blind, randomized, placebo-controlled phase III intergroup study of gefitinib (G) in patients (pts) with advanced NSCLC, non-progressing after first-line platinum-based chemotherapy (EORTC 08021-ILCP 01/03).. Journal of Clinical Oncology. 28(15_suppl). 7518–7518. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact